The DRUGMATRIX assay is a laboratory test that measures radioligand binding of AB-MECA to the Adenosine A3 protein target. This protein target is homologous and consists of a single protein. The assay uses CHO-K1 cells and membrane subcellular fraction for testing purposes. Additionally, the assay type is in vitro and is specifically designed for assessing binding properties of the protein target. Does this assay find the molecule effective?